Transgenic mouse line overexpressing the cancer-specific tNOX protein has an enhanced growth and acquired drug-response phenotype

Journal of Nutritional Biochemistry

Volumn 17, Issue 11, 2006, Pages 750-759

  Yagiz, Kader ^a   Morré, D James ^b   Morré, Dorothy M ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

( ) Epigallocatechin 3 gallate (EGCg); ECTO NOX; Growth; NADH oxidase; tNOX; Transgenic mouse

Indexed keywords

DRINKING WATER; EPIGALLOCATECHIN GALLATE; HEMAGGLUTININ; HERPESVIRUS VECTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TUMOR ASSOCIATED REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BODY WEIGHT; CARCASS; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; DRUG TARGETING; FEMALE; GENE OVEREXPRESSION; GROWTH RATE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; TRANSGENIC MOUSE; WILD TYPE;

ACUTE TOXICITY TESTS; ANIMALS; BODY WEIGHT; CATECHIN; CELL MEMBRANE; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; GENOTYPE; MICE; MICE, TRANSGENIC; NADH, NADPH OXIDOREDUCTASES; PHENOTYPE; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; SPECTROPHOTOMETRY; SURVIVAL RATE;

MUS MUSCULUS;

EID: 33748949820     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2005.12.006     Document Type: Article

References (40)

1. Chueh P.J., Kim C., Cho N., Morré D.M., and Morré D.J. Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. Biochemistry 41 (2002) 3732-3741
2. Morré D.J., Bridge A., Wu L.Y., and Morré D.M. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol 60 (2000) 937-946
3. Chueh P.J., Wu L.Y., Morré D.M., and Morré D.J. tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. BioFactors 20 (2004) 235-249
4. Stoner G.D., and Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem 22 (1995) 169-180
5. Chen Z.P., Schell J.B., Ho C.T., and Chen K.Y. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett 129 (1998) 173-179
6. Cooper R., Morré D.J., and Morré D.M. Medicinal benefits of green tea: Part II. Review of anticancer properties. J Altern Complement Med 11 (2005) 639-652
7. Pillai S.P., Mitscher L.A., Menon S.R., Pillai C.A., and Shankel D.M. Antimutagenic/antioxidant activity of green tea components and related compounds. J Environ Pathol Toxicol Oncol 18 (1999) 147-158
8. Ahmad N., Feyes D.K., Nieminen A.L., Agarwal R., and Mukhtar H.J. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst 89 (1997) 1881-1886
9. Hayakawa S., Saeki K., Sazuka Y., Sziki Y., Shoji Y., Ohta T., et al. Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun 285 (2001) 1102-1106
10. +/NAD(P)H. Mol Cell Biochem 273 (2005) 161-167
11. Chueh P.J., Morré D.M., Penel C., DeHahn T., and Morré D.J. The hormone-responsive NADH oxidase of the plant plasma membrane has properties of a NADH: protein disulfide reductase. J Biol Chem 272 (1997) 11221-11227
12. Morré D.J., Chueh P.J., Lawler J., and Morré D.M. The sulfonylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol interchange activity. J Bioenerg Biomembr 30 (1998) 477-487
13. Morré D.J. NADH oxidase: a multifunctional ectoprotein of the eukaryotic cell surface. In: Asard H., Bérczi A., and Caubergs R. (Eds). Plasma membrane redox systems and their role in biological stress and disease (1998), Kluwer Academic Publishers, Dordrecht (The Netherlands) 121-156
14. Morré D.J. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-4(4-methylphenylsulfonyl)-N-(4-chlorophenyl)urea (LY181984) at an external site. Biochim Biophys Acta 1240 (1995) 201-208
15. Morré D.J., Wilkinson F.E., Kim C., Cho N., Lawrence J., Morré D.M., et al. Antitumor sulfonylurea-inhibited NADH oxidase of cultured HeLa cells shed into media. Biochim Biophys Acta 1280 (1996) 197-206
16. Morré D.J., Caldwell S., Mayorga A., Wu L.Y., and Morré D.M. NADH oxidase activity from sera altered by capsaicin is widely distributed among cancer patients. Arch Biochem Biophys 342 (1997) 224-230
17. Morré D.J., and Reust T. A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4-(methylphenylsulfonyl)-N′-(4-chlorophenyl)urea LY181984) specific to sera from cancer patients. J Bioenerg Biomembr 29 (1997) 281-289
18. Cho N., Chueh P.J., Caldwell S., Morré D.M., and Morré D.J. Monoclonal antibody to a cancer-specific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients. Cancer Immunol Immunother 51 (2002) 121-129
19. Morré D.J., Chueh P.J., and Morré D.M. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci U S A 92 (1995) 1831-1835
20. Taketo M., Schroeder C.A., Mobraaten E.L., Gunning K.B., Hanten G., and Fox R.R. FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A 88 (1991) 2065-2069
21. Sambrook J., Fristch E.F., Maniatis T., Ford N., Nolan C., and Ferguson M. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY) 6.23
22. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
23. Morré D.J., and Morré D.M. Mammalian plasma membranes by aqueous two-phase partition. BioTechniques 7 (1989) 946-958
24. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
25. Smith P.K., Krohn R.I., Hermanson G.T., Malia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
26. Morré D.J., and Morré D.M. Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases. Free Radic Res 37 8 (2003) 795-808
27. Okabe S., Suganuma M., Eisaburo S., and Fujiki H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 88 (1997) 639-643
28. Yang C.S., and Wang Z.Y. Tea and cancer. J Natl Cancer Inst 85 (1993) 1038-1049
29. Hiroyuki S., Tomoko O.H., Tsuneji S., Imad N., Toshiyuki S., Katsutoshi T., et al. Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-199. Mol Cancer Ther 1 (2002) 657-665
30. Kavanagh K.T., Hafer L.G., Kim D.W., Mann K.K., Sherr D.H., Rogers A.E., et al. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J Cell Biochem 82 (2001) 387-398
31. Scalbert A., and Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 130 (2000) 2073S-2085S
32. Kim S., Lee M.J., Hong J., Li C., Smith T.J., Yang G.-Y., et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer 37 (2000) 41-48
33. Lee M.J., Wang Z.Y., Li H., Chen L., Sun Y., Gobbo S., et al. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol Biomarkers Prev 4 (1995) 393-399
34. Hollman P.C.H., van der Gaag M., Mengelers M.J.B., van Trijp J.M.P., de Vries J.H., and Katan M.G. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 21 (1996) 703-707
35. Kivits G.A.A., van der Sman F.J.P., and Tijburg L.M.B. Analysis of catechins from green tea and black tea in humans: a specific and sensitive colorimetric assay of total catechins in biological fluids. Int J Food Sci Nutr 48 (1997) 387-392
36. Aziz A.A., Edwards C.A., Lean M.E.J., and Crozier A. Absorption and excretion of conjugated flavonols, including quercetin-4′-O-beta-glucoside and isorhamnetin-4′-O-beta-glucoside by human volunteers after the consumption of onions. Free Radic Res 29 (1998) 257-269
37. Macleod K.F., and Jacks T. Insights into cancer from transgenic mouse models. J Pathol 187 (1999) 43-60
38. Largaespada D.A. Genetically modified mice in cancer research. Methods Mol Biol 209 (2003) 311-332
39. Sung Y.H., Song J., and Lee H.W. Functional genomics approach using mice. J Biochem Mol Biol 37 (2004) 122-132
40. Andrechek E.R., and Muller W.J. Tyrosine kinase signaling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer. Breast Cancer Res 2 (2000) 211-216